Justin Watts, Gautam Borthakur, Tara Lin, Nashat Gabrail, Kruti Patel, Yazan Madanat, Joshua Zeidner, Noor Khaskhely, Lynn Bonham, Michelle Nelson, John Kumer, Daphne Taylor, Caroline Taromino, Miriam Weber Miller, Dirk Huebner, Michael Maris. "A dose optimization phase 1b/2 study evaluating mipletamig (formerly APVO436), a novel bispecific CD123 x CD3 ADAPTIRÒ molecule in combination therapy for the treatment of frontline acute myeloid leukemia (AML) in patients unfit for intensive chemotherapy." Blood (2025). https://doi.org/10.1182/blood-2025-5198